Progestin-only systemic hormone therapy for menopausal hot flashesFebruary 7, 2020MenopauseGynecology
Does BSO status affect health outcomes for women taking estrogen for menopause?November 5, 2019MenopauseGynecologyHysterectomyOsteoporosisSurgeryPreventive CareFemale Sexual Dysfunction
Product Update: Addyi alcohol ban lifted, fezolinetant trial, outcomes tracker, comfort gownNovember 4, 2019GynecologyObstetricsFemale Sexual DysfunctionMenopausePractice Management
What does the REPLENISH trial reveal about E2/P4’s ability to affect VMS and sleep and appropriate dosing for smokers?October 16, 2019MenopauseGynecology
Postmenopausal women would benefit from clinician-initiated discussion of GSM symptomsOctober 16, 2019MenopauseGynecologyPreventive Care
Can we discern optimal long-term osteoporosis treatment for women?October 1, 2019OsteoporosisGynecologyMenopause
Product Update: Osphena’s NDA, new hysteroscope, TempSure RF technology, Resilient stirrup coversAugust 8, 2019GynecologyObstetricsMixed TopicsPreventive CareReproductive EndocrinologySurgeryMenopause
Office hysteroscopic evaluation of postmenopausal bleedingAugust 6, 2019GynecologyGynecologic CancerMenopauseSurgery
Is vaginal estrogen used for GSM associated with a higher risk of CVD or cancer?February 5, 2019MenopauseGynecology
Does the type of menopausal HT used increase the risk of venous thromboembolism?February 5, 2019Menopause
